News
A two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings ...
South Korea's top court clears SK Bioscience’s vaccine of patent violation, unlocking export potential and global market ...
Critical voices on unfairly high mpox and other vaccine prices open the debate on the ‘right price’ to be paid to private vaccine suppliers. We apply compound real options analysis as a more ...
In a landmark advancement for public health infrastructure, South Sudan has formally integrated two vital childhood vaccines ...
RFK Jr. and other public health officials announced the COVID vaccine won't be recommended for healthy children and pregnant women.
South Sudan has introduced the pneumococcal conjugate vaccine (PCV) and rotavirus vaccine into its national immunization ...
Pneumococcal meningitis was associated with a case-fatality rate of almost 30% in children with sickle cell disease, a study ...
South Sudan, in partnership with United Nations agencies, on Tuesday launched two vaccines to prevent pneumonia and severe ...
Somalia has once again reaffirmed its commitment to reducing maternal and child mortality by participating in a crucial international summit focused on improving health outcomes for mothers and ...
Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...
SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...
Supreme Court upholds lower court's decision that SK bioscience's PCV13 components do not fall within scope of Pfizer's patent claims - Anadolu Ajansı ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results